In the second positive piece of COVID-19 vaccine news in a week, Russia’s Sputnik V candidate has been shown to be 92% effective at the interim point of a 40,000-patient study.
The latest Nation’s Report Card test scores are dismal and heartbreaking. The crash that started with inexcusable ...
Russia's stride in cancer vaccine development follows its notable achievement in combating the COVID-19 pandemic. The country ...
The Russian Ministry of Health registered the nasal version of the COVID-19 vaccine Sputnik V, developed by the Gamaleya Institute of that country. The injectable immunizer was the first to be ...
Sputnik 1 was launched on October 4 ... in the booster also failed around 16 seconds into launch. Eventually, at 19.9 seconds ...